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a b s t r a c t
Antioxidant defences are comparatively low during foetal development making the brain particularly
susceptible to oxidative stress during antioxidant deﬁciencies. The brain is one of the organs containing
the highest concentration of vitamin C (VitC) and VitC deﬁciency during foetal development may place
the brain at risk of redox status imbalance. In the present study, we investigated the developmental
pattern and effect of VitC deﬁciency on antioxidants, vitamin E and superoxide dismutase (SOD),
assessed oxidative damage by measuring malondialdehyde (MDA), hydroxynonenal (HNE) and nitrotyr-
osine (NT) and analysed gene and protein expression of apoptosis marker caspase-3 in the guinea pig
foetal brain at two gestational (GD) time points, GD 45/pre-term and GD 56/near term following either
a VitC sufﬁcient (CTRL) or deﬁcient (DEF) maternal dietary regime. We show that except for SOD,
antioxidants and oxidative damage markers are differentially expressed between the two GDs, with high
VitC (po0.0001), NT modiﬁed proteins (po0.0001) and active caspase-3 levels (po0.05) at pre-term
and high vitamin E levels (po0.0001), HNE (po0.0001) and MDA (po0.0001) at near term. VitC
deﬁciency signiﬁcantly increased SOD activity (po0.0001) compared to CTRLs at both GDs indicating a
compensatory response, however, low levels of VitC signiﬁcantly elevated MDA levels (po0.05) in DEF at
near term. Our results show a differential regulation of the investigated markers during late gestation
and suggest that immature brains are susceptible to oxidative stress due to prenatal vitC deﬁciency in
spite of an induction of protective adaptation mechanisms.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
The developing brain has a high metabolic activity making it
vulnerable to oxidizing agents such as free radicals [55], a situation
that is further exacerbated by a yet immature scavenging anti-
oxidant system in early life [33,48]. Although antioxidant defence-
mechanisms in guinea pig brains during foetal development have
been investigated [36], the manifestation of macromolecular
modiﬁcations due to lipid peroxidation or by similar oxidizing
agents and cell death in the near term brain is unknown. It is also
not known if the pertinent oxidative changes during development
are likely to increase in the brain when deprived of optimal
antioxidant levels.
Guinea pigs are precocial rodents with a gestation length of
approximately 66 days with the peak of exponential brain growth
(‘the brain growth spurt’) being reached about 15 days before birth
(i.e. around gestation day (GD) 50) [12]. Interference with optimal
requirements for the foetus may impose several negative effects
on developmental outcome such as lower body weight [11] and in
the brain lead to reduction of cells in hippocampal morphogenesis
[4] and cognitive alterations as observed in rats [38]. Oxidative
stress caused by deﬁciency in antioxidants like glutathione in the
developing brain has been shown to negatively affect mitochon-
dria [21] and also to result in an age-dependent neurodegenera-
tion in the hippocampus [1].
Activity of antioxidant enzymes in guinea pigs such as super-
oxide dismutase, catalase, glutathione peroxidase (GPx) and glu-
tathione reductase have been demonstrated to remain constant
from GD 30 to 45 and to increase from GD 45 to GD 60, with the
exception of superoxide dismutase (SOD) that remained constant
throughout the GD 30–60 period [36]. In rats, postnatal GPx
activity in the brain has been found to remain constant from birth
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whereas the activity of cytoplasmic SOD increases from birth until
60 days after birth in rats [34]. Analysis of antioxidant protein
levels in developing mice brains from embryonic day 18 to
postnatal day 21 has shown that total SOD activity, catalase and
GPx activity increases suggesting an increase in antioxidants in
perinatal and neonatal brains relative to foetal development [25].
Thus, despite inter-species differences and differences in degree of
postnatal development (i.e. altrician vs. precocial species), there
seems to be a general trend of increasing antioxidant capacity in
the brain during the course of development. Hence, a decrease
in antioxidant capacity could potentially disturb the redox
homeostasis in the brain leading to negative consequences on
development.
Vitamin C (VitC) deﬁciency in humans has been associated with
increases in premature births and predisposing newborns’ to
oxidative stress [39,44]. VitC is one of the primary antioxidants
in the brain and selectively accumulates in high amounts also
during foetal development [14,26,33]. Interruption of vitC trans-
port to the brain in the svct2/ mouse is detrimental to
perinatal survival [13,50], underlining the pivotal role of vitC in
the developing central nervous system. Due to its one electron
reduction potential, VitC effectively inhibits lipid peroxidation and
scavenges several reactive oxidizing compounds such as super-
oxide, hydrogen peroxide and hydroxyl radicals as well as enabling
the recycling of other antioxidant compounds such as vitamin E
[7,20,30,49]. In guinea pigs, VitC deﬁciency during both pre- and
postnatal development has been linked to deviations in hippo-
campal development [51,52]. Alteration of apoptotic mechanisms
due to redox imbalance in the foetal brain has also been reported
in several studies, however, the underlying mechanism and
potential cause vs consequence remains to be disclosed [19,43].
Like humans, guinea pigs cannot synthesize VitC due to a non-
functional gulonolactone oxidase (Gulo) gene [40] and therefore
rely on an adequate dietary supply. The present study investigated
the developmental course of and potential effects of VitC deﬁ-
ciency on markers of antioxidants, redox imbalance and apoptosis
signalling in foetal guinea pig brains at two different gestational
time points at which brain growth is at a peak, GD 45/pre-term
and GD 56/near term.
Materials and methods
Animal experiment
The animal study adheres to the guidelines of EU Directive
2010/63/EU and was approved by Danish Animal Experimentation
Inspectorate. Twenty pregnant guinea pigs between GD 6–10 were
obtained from Charles Rivers Lab, Kieslegg, Germany. The animals
were microchipped subcutaneously (PET-CHIP ID, Danworth farm,
West Sussex, UK) and randomized according to GD and body
weight into two groups receiving diets only differing in VitC
content (specialized diets sniff, GmbH), Control: CTRL (900 mg/
kg diet, n¼10) and Deﬁcient: DEF (100 mg/kg diet, n¼10). It has
previously been shown by us that the 100 mg VitC diet in guinea
pigs results in non-scorbutic VitC deﬁciency [32,53]. Each of the
groups was further randomized to having caesarian section
(followed by euthanasia) performed at GD 45 or GD 56. The
animals were housed in ﬂoor pens with straw bedding and feed,
hay and water were provided ad libitum. They were weighed once
every week and blood was sampled (300 ml) once in every two
weeks from v. saphena at its superﬁcial course on tibia to verify
VitC status (data not shown).
At euthanasia three dams, one from CTRL group and two from DEF
group were found not to have conceived. Necropsy revealed no signs
of underlying disease and the animals were excluded from the study.
Euthanasia
Caesarean section was conducted on dams at GD 45 or GD 56.
Ten to ﬁfteen minutes prior to anaesthesia, dams were injected
with 2 mg/kg body weight Torbugesic (10 mg/ml butorphanol,
Scan Vet Animal Health, Fredensborg, Denmark) subcutaneously
to achieve analgesia. Anaesthesia was achieved by inhalation of
isoﬂurane (Isoba Vet 100%, Intervet International, Boxmeer, The
Netherlands). After the disappearance of voluntary reﬂexes (inter-
digital and skin-pinch), caesarean was performed by laparotomy
through linea alba exposing the uterus. Excision of fetuses was
done one at a time starting from the apex of the left horn towards
the basis and subsequently commencing at the apex of the right
horn. Immediately following delivery of each pup, the body weight
was recorded, an intracardial blood sample was taken and the pup
was euthanized by decapitation, the procedure lasting no more
than 2 minutes. In the event of a pup displaying reﬂexes,
euthanization by intraperitoneal injection of 0.5 ml pentobarbital
(200 mg/ml) supplemented with lidocaine (Veterinary Pharmacy,
University of Copenhagen, Denmark) was performed. Gender was
recorded and post mortem autopsy with tissue sampling was
performed on each pup, tissues allocated either to ﬁxative or
frozen for later analysis. Blood samples were centrifuged, stabi-
lized and frozen after the intracardial blood sampling of the ﬁnal
pup from each dam. Once all the pups were removed from the
uterus, thoracotomy of the damwas performed and an intracardial
blood sample was taken before sacriﬁcing by decapitation and
exsanguination.
The brain was removed and the left hemisphere frozen in liquid
nitrogen and the right hemisphere ﬁxated in 4% PFA (paraformal-
dehyde in phosphate buffered saline, 0.15 M, pH 7.5) for 48 h then
transferred to 1%PFA for long term storage.
All frozen tissues were stored at 80 1C until further analysis.
For the current study all foetal left brain hemispheres from a total
of 85 fetuses, were blocked for gender and body weight and
randomized to be used for gene and protein expression analysis
(N values; 12 CTRL/GD 45, 9 DEF/GD 45, 10 CTRL/GD 56, 11 DEF/GD
56) or biochemistry (N Values; 12 CTRL/GD 45, 10 DEF/GD 45, 10
CTRL/GD 56, 11 DEF/GD 56).
Biochemistry
Analysis of VitC and malondialdehyde (MDA) in brain were
performed as described previously [28,29,31]. Brieﬂy, tissue
samples (app. 0.5 g) were homogenized in PBS, centrifuged at
16,000 g for 1 min at 4 1C. For VitC analysis, an aliquot was
stabilized with an equal volume of 10% meta-phosphoric acid
containing 2 mM EDTA (Merck, Whitehouse Station, NJ, USA),
centrifuged, and the supernatant analysed by high-performance
liquid chromatography (HPLC) with colorimetric detection. Levels
of MDA were assessed by thiobarbituric acid derivatization fol-
lowed by speciﬁc quantiﬁcation of the genuine MDA(TBA)2 adduct
by HPLC with ﬂuorescence detection.
Analysis of α-tocopherol and γ-tocopherol was performed by HPLC
with coulometric detection as modiﬁed from Sattler et al. [46]. Brieﬂy,
to 100 ml of tissue homogenate was added 25 ml freshly prepared
2,6-di-tert-butyl-p-cresol (10 mg/ml; Sigma, Copenhagen, Denmark),
100 ml sodium dodecyl sulphate (29 mg/ml, Sigma), 800 ml H2O, 900 ml
ethanol and 100 ml 2-propanol. The cold mixture was extracted with
1 ml of n-hexane (Merck, Damstadt, Germany) of which 500 ml of
organic phase was reduced to dryness at 40 1C using an airstream and
subsequently redissolved in 100 ml ethanol for 2 min using a vortex
mixer. Following centrifugation, 20 ml of the supernatant was used for
HPLC analysis. Superoxide dismutase activity (SOD) was analysed
using the Ransod colorimetric assay (SD125, Randox Laboratories
Limited, UK) on tissue lysates according to manufacturer’s instructions.
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RNA extraction and RT-PCR
Approximately 25 mg of each of brain tissues was homogenized
in trizol (InVitrogen, Merelbeke, Belgium) and precipitated with
chloroform (Sigma Aldrich, Steinheim, Germany) and isopropanol
(Merck, Darmstadt, Germany). Puriﬁed RNA (SV Total RNA Isola-
tion System, Promega, Madison, WI, USA) was eluted with 50 ml
nuclease free water and the purity of RNA was determined by
absorbance ratios A260/A280 and A260/A230 (Nanodrop 2000;
Thermo Scientiﬁc, Wilmington, DE, USA). cDNA synthesis was
performed by RT-PCR with 2 mg of RNA (MmLV RT enzyme,
5MmLV buffer and RNasin (Promega)); 10 mM dNTPs and Oligo
(dT) primers (60 mg/120 ml) (Fermentas GmbH, St Leon Roth,
Germany); Random hexamer primer (2 mg/ml) (GE Healthcare,
Uppsala, Sweden).
Gene expression analysis
Intron-spanning beta-actin primers were used on all cDNA
(Table 1) prior to real time quantitative PCR (Q-PCR) to test for
genomic contamination. None of the included samples displayed
signs of contamination. PCR products of included genes were
run on 2% agarose gels to conﬁrm the product size and were
then puriﬁed by PCR clean-up (PCR Clean Up System; Promega,
Sweden) and subsequently submitted for sequencing (LGC geno-
mics, Berlin, Germany) to conﬁrm speciﬁcity.
Q-PCR was conducted (SYBR Green I master LC480 and LC480,
Roche, Basel, Switzerland) in 96-well white plates (Roche, Man-
nheim, Germany) with all samples in triplicates (in dilution 1:5),
nuclease free water as negative control and calibrator as positive
control. Gene expression analysis of Caspase 3 from brain samples
was normalized to the reference gene, s18 (ribosomal protein S18).
Primers are listed in Table 1.
Protein extraction and Western blot
Protein was extracted from brain tissue with radio-immuno-
precipitation assay buffer (RIPA: 150 mM sodium chloride, 1%
Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl
sulphate, 50 mM Tris, pH 8) with 1:100 protease inhibitors (Sigma
complete protease inhibitor cocktail). Estimation of protein was
done by bicinchoninic acid assay (Calbiochem Novagen BCA
Protein Assay kit), according to the manufacturer’s protocol, in
triplicates at 562 nm on a SpectraMax Plus 384 UV/VIS plate
reader (Molecular Devices Inc., CA, USA).
Approximately 100 mg of protein diluted with reducing agent
and loading buffers (Invitrogen NuPAGE 4X LDS sample buffer,
Invitrogen NuPAGE 10X sample reducing agent) were heated at
70 1C for 10 min before loading on precast gels (Invitrogen NuPAGE
4–12% Bis-Tris gels) in duplicates together with an internal
standard comprising equal volumes of all samples. Gel to PVDF
membrane transfer of protein was performed in a semi dry
transfer unit (TE 77PWR, Amersham Biosciences) prior to 1 h
blocking in 2% blocking buffer (Amersham ECL Prime Blocking
Agent in PBS-T wash buffer,1XPBS and 0.1% Tween) before incuba-
tion with cleaved anti-caspase-3 (9661, Cell Signaling Technology,
Danvers, MA, USA) or 4% blocking buffer before incubation with
anti-nitrotyrosine (anti-NT, 06-284, Millipore, Temecula, CA)
or anti-4-hydroxynonenal (anti-HNE, HNE 11-S, Alpha Diagnostic
International, San Antonio, TX, USA). Antibody speciﬁcity of
cleaved caspase-3 was tested by pre-absorption with equal volume
of the blocking peptide (#1050, Cell Signaling Technology,
Danvers, MA, USA) and speciﬁcity of anti-nitrotyrosine was tested
by pre-absorption of 0.5 mg/ml primary antibody with 15 mM free
NT (#89540, Cayman Chemical, Ann Arbor, MI, USA) with respec-
tive controls (#9663 Caspase-3 control Cell signalling technology,
Danver, MA, USA); (#12–354, NT immunoblotting control, Chemi-
con, Temecula, CA, USA). Membranes were incubated with primary
antibody overnight at 4 1C (1:1000, cleaved caspase-3 or 0.5 mg/ml
anti-NT or 1:2000 anti-HNE), followed by secondary antibody
(anti-rabbit IgG-HRP, 7074, Cell Signaling Technology, Danvers,
MA, USA) 1: 1000, 1:6000 and 1:2000 for anti-caspase-3, anti-NT
and anti-HNE proteins respectively. Imaging was achieved by
enhanced chemiluminiscence (Amersham ECL Prime Western
Blotting Reagent, UVP Biospectrum imaging system). Band-sizes
were identiﬁed by Western blot protein standard (Magic MarkTM
XP Western Protein Standard). Cleaved caspase-3 bands were
located by an additional protein standard (ECL DualVue Western
Blotting Markers, RPN810, Amersham Biosciences) with a speciﬁc
secondary antibody (1:10000, HRP-S) diluted together with the
secondary antibody. The NT and HNE blots were stripped with
0.5 M sodium hydroxide (Merck, Darmstad, Germany) before
re-probing with loading control (mouse anti-actin, 1:20000, MAB
1501, Millipore, Temecula, CA, USA). Target bands of cleaved
caspase-3 or lanes in case of NT and HNE blots were normalized
to the loading control, detected by anti-mouse IgG-HRP secondary
antibody (1:10000, SC-2005, Santa Cruz Biotechnology, CA, USA).
UVP Life Science Series Image Acquisition and Analysis software
was used for densitometry and blots were normalized to an
internal control.
Statistics
SAS/JMP statistical version 8.0 was used to analyse all data.
Analysis of Q-PCR expression data was performed by Student’s
t-test. Two-way ANOVA was used to analyse biochemistry and
Western blot densitometry. Interaction between factors, diet and
GD, was reported together with main effects when statistically
signiﬁcant (po0.05) followed by Tukeys HSD posthoc comparisons.
Results
Brain antioxidant status
As shown in Table 2, VitC concentration in the brain was
signiﬁcantly higher in the CTRL groups of both gestational days
compared to DEF counterparts (po0.0001). Two-way ANOVA
showed effects of both diet and GD (po0.0001) on VitC levels as
well as an interaction between diet and GD (po0.0001). A decrease
of approximately 20% in VitC was observed in CTRL GD 56 relative to
GD 45 (po0.0001).This was not found in the DEF group, where VitC
levels did not differ between gestational dates. In contrast to total
VitC in the brain, α-tocopherol levels were high on GD 56 relative to
GD 45 (po0.0001) with no signiﬁcant effect of diet. Conversely, two-
way ANOVA showed a signiﬁcant effect of diet on γ-tocopherol
(po0.05), the DEF-group displaying overall increased levels. How-
ever, tocopherols were not signiﬁcantly different between CTRL and
Table 1
Primer sequences applied in the gene expression analysis.
Gene Primer sequence Product size (bp) NCBI accession no.
Beta-
actin
(F): gtaaggacctctatgccaacaca 346 AF508792
(R): atgccaatctcatctcgttttct
s18 (F): atgtggtgttgaggaaagcag 195 XM_003473925.1
(R): gcttgttgtccagaccgttg
Caspase-3 (F): ctggaatggcacctcgactt 315 XM_003469171.1
(R): ccccggcaagcctgaataat
Sequences are presented in the 50–30 direction (F): forward, (R): reverse.
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DEF groups at the individual time-points. SOD was signiﬁcantly
increased by VitC deﬁciency (po0.0001) but was not affected by GD.
Brain oxidative damage
Western blot of HNE modiﬁed proteins ranged between 20 and
120 kDa in guinea pig brain lysates (data not shown). Two-way
ANOVA of densitometry data showed that the intensity of HNE
modiﬁcations at GD 56 was twice as high as GD 45 with a
signiﬁcant effect of GD (po0.0001) (Fig. 1A). However, no sig-
niﬁcant differences were found between CTRL and DEF groups at
either gestational day. MDAwas measured in brain homogenate as
a marker of lipid oxidation. Two-way ANOVA showed signiﬁcant
effects of both diet (po0.001) and gestational age (po0.0001).
In agreement with the anti-HNE densitometry data, MDA was
signiﬁcantly elevated at GD 56 compared to 45 for both dietary
regimens separately (po0.0001). Moreover, VitC deﬁciency
resulted in increased brain MDA compared to controls at GD 56
(po0.05) but at GD45, the increase did not reach statistical
signiﬁcance (Fig. 1B).
NT modiﬁed proteins were detected by Western blotting
between 35 and 15 kDa in brain lysates. Pre-absorption of primary
antibody with free NT abolished all the bands in guinea pig brain
lysate and almost all bands in the positive control conﬁrming
speciﬁcity of the antibody (data not shown). A signiﬁcant main
effect of GD (po0.0001) was detected with highest levels of NT
modiﬁed proteins in GD 45 brains (Fig. 1C). There was no
detectable effect of diet on the level of NT modiﬁed proteins at
either gestational day.
Caspase-3 expression
Q-PCR analysis of caspase-3 gene-expression in the brain
was not signiﬁcantly different between CTRL and DEF groups in
either gestational day (Fig. 2A). Cleaved caspase-3 Western blot-
ting showed a single band just below 15 kDa. Pre-absorption of
primary antibody with blocking peptide abolished the speciﬁc
bands from guinea pig brain lysate and the positive control
conﬁrming the speciﬁcity of the antibody (data not shown).
Two-way ANOVA of densitometry data showed that GD had a
signiﬁcant effect on cleaved caspase-3 (po0.05) with higher levels
at GD 45 compared to GD 56 (Fig. 2B). Densitometry analysis
at either gestational day did not show signiﬁcant differences
between CTRL and DEF groups (Fig. 2B).
Discussion
In the present study, we show that immature brains are suscep-
tible to oxidative stress in spite of an induction of protective
adaptation mechanisms. Oxidative stress and damage markers in
guinea pig cerebral cortex were assessed at preterm and near term
gestational time points with and without maternal VitC deﬁciency as
a potential oxidative insult.
Brain VitC levels in DEF groups were signiﬁcantly lower than
CTRL as expected, and while VitC levels in the DEF group remained
similar at the two gestational days, VitC in GD 56 CTRL was
signiﬁcantly lower than GD 45 CTRL. This ﬁnding indicates a
developmental requirement of increased VitC during the preterm
period possibly as a response to lower protective mechanisms
against oxidizing agents as has previously been suggested [36].
However, in contrast to CTRLs, the DEF group did not display a
near-term drop in concentration but rather showed retention of
VitC, possibly to avoid any further loss than the already existing
low level. The decrease in VitC toward term in CTRL animals
is in line with ﬁndings in humans reporting a late gestation
decrease of VitC in all foetal tissues including the brain [58,59].
This decrease in the brain has been suggested to be due to growth
Table 2
Brain antioxidant status in prenatally VitC deﬁcient and control guinea pigs at GD 45 and GD 56.
CTRL GD 45 CTRL GD 56 DEF GD 45 DEF GD 56 Effect of VitC Effect of GD
VitC (nmol/g tissue) 30437285a 23517137b 10167270c 9667242c nnn nnn
α-Tocopherol (nmol/g tissue) 5.570.8b 9.071.0a 4.671.0b 9.471.5a NS nnn
γ-Tocopherol (nmol/g tissue) 0.5270.46 0.5070.36 0.8070.5 0.8970.39 n NS
Superoxide dismutase (U/g tissue) 9072a 9272a 13373b 13774b nnn NS
CTRL: controls; DEF: deﬁcient. GD: gestational day. Values are presented as means7SD. Differences between groups were assessed using two-way ANOVA with diet and GD
as factors followed by Tukeys HSD test for individual comparisons. NS: not signiﬁcant. Different superscript letters indicate that groups are signiﬁcantly different.
npo0.05.
nnpo0.001.
nnnpo0.0001.
Fig. 1. Oxidative damage in foetal guinea pig brains. Markers of increased oxidation and suggestive oxidative damage in the brain of guinea pigs subjected to prenatal vitC
deﬁciency (DEF) (dark bars) or control diet (CTRL) (light bars) during development. Foetuses were excised by caesarean section at GD 45 and GD 56. (A) Densitometric
analysis of HNE modiﬁed proteins in brain homogenate; results are normalized to actin; (B) Malondialdehyde in brain homogenate, measured by HPLC; (C). Densitometric
analysis of nitrotyrosine modiﬁed proteins normalized to actin. Data are expressed as means7SD. npo0.05; nnnpo0.0001 by ANOVA.
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and maturation of non-neuronal cells and maturation and myelina-
tion of neurones [16,59]. Recent studies by us have shown that a pre-
natal low VitC causes a reduction in foetal body and brain weight at
GD 45 but not at GD 56 (unpublished results), indicating that a
developing foetus is able to compensate for a pre-imposed negative
effect of VitC deﬁciency during the ﬁnal weeks of gestation.
Our α-tocopherol data implies that it increases with progres-
sion in development during late gestation. Interaction between
cytosolic VitC and membrane bound vitamin E regenerates oxi-
dized vitamin E and results in an efﬁcient antioxidant mechanism
[9], which suggests that VitC deﬁciency may alter vitamin E levels
hereby possibly disrupting membrane integrity. Some in-vivo
studies have shown that intake of high VitC results in an increased
vitamin E in tissues [5,17,18]. This was not the case when
evaluating α-tocopherol in CTRL vs. DEF groups of this study,
however, VitC showed a main effect on γ-tocopherol levels in the
brain. γ-Tocopherol has been associated with anti-inﬂammatory
properties, decreased superoxide anion generation and inhibition
of lipid peroxidation, hereby reducing adverse effects of oxidative
imbalance [23,45]. Our present ﬁndings suggest an increase in
γ-tocopherol in response to VitC deﬁciency, whereas levels during
late gestational progression were relatively constant in both CTRL
and DEF groups.
In the current study, VitC deﬁciency increased SOD activity
during late gestation. SOD activity in CTRL groups at both GD is in
agreement with a previous report of constant SOD levels in guinea
pig foetal brains throughout gestation from GD 30 to GD 60 [36].
As a consequence of low VitC levels, increases in SOD activity in
DEF compared to CTRLs at both GD indicates foetal ability to
induce a compensatory mechanism, likely due to increased pro-
duction of superoxide radicals [24]. Various studies have reported
an increase in SOD activity in the brain as an adaptive mechanism
to tolerate oxidative damage in neurodegenerative conditions [41],
stress [10] and oxidant induced neurotoxicity [6]. Studies like these
with additional assessment of antioxidants like catalase, glutathione
peroxidase or oxidative damage markers helps in understanding
whether such adaptive mechanisms are able to preserve the redox
status [3,57].
HNE modiﬁed proteins, which indicate oxidative damage due
to lipid peroxidation, were signiﬁcantly high at GD 56, regardless
of VitC status, likely due to the increase in poly-unsaturated fatty
acids in the brain at near term. An increased susceptibility of lipid
peroxidation in near term brains of guinea pigs has previously
been reported [37]. Although HNE modiﬁed proteins were not
signiﬁcantly different between CTRL and DEF, a trend similar to the
obtained MDA levels was observed between the two GD, with
signiﬁcantly higher MDA levels at near term further supporting
the maturational related increase of lipid peroxidation in the brain
as reported by others in guinea pigs brain [37]. Signiﬁcant increase
of MDA levels in DEF at GD 56 and not in DEF at GD45 compared to
their CTRL suggests that compensatory mechanisms that may have
been present at earlier gestation may not be enough to protect
from lipid peroxidation due to low levels of VitC in the brain.
Earlier studies by us and others have shown a similar inverse
relation of VitC levels to lipid peroxidation in the brain [15,33] and
the vital role of ascorbate has previously been demonstrated to
inhibit lipid peroxidation in rat brain microsomes [47]. Conversely,
no signiﬁcant differences in NT modiﬁed proteins between CTRL
and DEF suggests that posttranslational modiﬁcation of proteins
by NT is not effected by VitC deﬁciency and instead, as proposed
by others, NT may be involved in mediating cell signalling at its
basal levels during development [27,35].
Results from oxidative stress based in-vivo studies have sug-
gested an increased free radical production or decreased antiox-
idant mechanisms in the immature brain [36,56], which in turn
may initiate cellular events to initiate mechanisms of apoptosis
[8,42] like caspase-3 activation [22]. Our ﬁnding of high levels
of cleaved caspase-3 in GD 45 compared to GD 56 indicates a
developmental phenomenon in agreement with what has been
shown by others [2], placing cleaved caspase-3 as playing an
important role in reducing neuronal overproduction in the devel-
oping brain [54]. The guinea pig is a precocial species and neuronal
number relative to adult stage are achieved by GD 48 [12]. Hence,
although a gestational effect was seen for cleaved caspase-3, the
difference was small implying that most of the cell death asso-
ciated with development is likely to have occurred before the
investigated time-points. No signiﬁcant differences in caspase-3
gene expression or cleaved caspase-3 protein levels between CTRL
and DEF groups at any of the GDs indicates that VitC deﬁciency
does not modulate caspase-3 mediated apoptosis and may not be
the underlying mechanism associated with hippocampal impair-
ment observed in our earlier ﬁndings [51,52].
Conclusion
Guinea pig foetal brains have differential requirements of
antioxidants with high VitC levels at pre-term, a higher require-
ment of α-tocopherol at near term and constant SOD activity.
Oxidative NT modiﬁcations and active caspase-3 levels are higher
at pre-term and are prone to increased lipid peroxidation at near
Fig. 2. Expression analysis of caspase-3 in the brain. (A) Quantitative PCR analysis
of caspase-3 in guinea pig foetal brains comparing vitC deﬁcient (dark bars) to
controls (light bars) on two gestational times points (GD45 and 56). Expressed
values are normalized to the reference gene s18 and displayed as mean7SD.
(B) Densitometric analysis of levels of cleaved caspase-3 obtained by Western blot
and normalized to actin levels. Data are expressed as means7SD. npo0.05
by ANOVA.
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term signifying differential expression of oxidative damage mar-
kers associated with brain maturity. Prenatal VitC deﬁciency in the
guinea pig foetal brain does not modulate levels of vitamin E, NT
or HNE protein modiﬁcations or caspase-3 however, increases SOD
activity as compensation although this is not adequate to prevent
increased lipid peroxidation at the investigated time points.
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